Cure rates for non–small-cell lung cancer (NSCLC) remain low and the prognosis for patients with even stage IA disease is poor. Complete surgical resection is still the first-line treatment for NSCLC, but many investigators
ONCOLOGY Vol 13 No 7_Suppl_3
Advertisement
Advertisement
Trending on CancerNetwork
1
Resecting MRI-Detected Disease Doesn’t Improve Outcomes in Early-Stage BC
2
Pembrolizumab/Radiation Improves T Cell Infiltration in Early Breast Cancer
3
Nivolumab/AVD Receives FDA Priority Review in Classical Hodgkin Lymphoma
4
Sacituzumab Govitecan Does Not Meet Statistical Significance in HR+/HER2– mBC
5
